|
Feb 24
|
What's in Store for These 5 Biotech Stocks This Earnings Season?
|
|
Feb 24
|
Stay Ahead of the Game With Viatris (VTRS) Q4 Earnings: Wall Street's Insights on Key Metrics
|
|
Feb 21
|
What's in the Cards for Viatris Stock This Q4 Earnings?
|
|
Feb 21
|
Q3 Earnings Outperformers: Viatris (NASDAQ:VTRS) And The Rest Of The Generic Pharmaceuticals Stocks
|
|
Feb 20
|
Earnings Preview: Viatris (VTRS) Q4 Earnings Expected to Decline
|
|
Feb 19
|
Uniting Against AMR: Global Solutions Need Local and Global Collaboration
|
|
Feb 19
|
Generic Pharmaceuticals Stocks Q3 Teardown: Amneal (NASDAQ:AMRX) Vs The Rest
|
|
Feb 18
|
3 Reasons to Sell VTRS and 1 Stock to Buy Instead
|
|
Feb 17
|
50 Years of Service: From Milkman's Son to Advancing Access to Medicines
|
|
Feb 14
|
Unpacking Q3 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) In The Context Of Other Generic Pharmaceuticals Stocks
|
|
Feb 13
|
ANI Pharmaceuticals (NASDAQ:ANIP): Strongest Q3 Results from the Generic Pharmaceuticals Group
|
|
Oct 1
|
Is Viatris Inc. (VTRS) the Best Stock Under $15 To Buy Now?
|
|
Sep 30
|
Viatris launches (Pr)Viagra® ODF in Canada: a new oral dissolving film form of the erectile dysfunction treatment
|
|
Sep 12
|
Viatris 2023 Sustainability Report: Advocating for Patients
|
|
Sep 12
|
Icon PLC (ICLR) Surges 3.3%: Is This an Indication of Further Gains?
|
|
Sep 10
|
Viatris Announces Expiration and Results of Any and All Cash Tender Offers
|
|
Sep 10
|
Viatris Announces the Pricing Terms of Pending Any and All Cash Tender Offers
|
|
Sep 9
|
Viatris 2023 Sustainability Report: Breaking Down Systemic Barriers To Access Through Policy Engagement
|
|
Aug 6
|
Why Is Viatris Inc. (VTRS) the Best Dividend-Paying Stock to Buy Under $15?
|
|
Aug 6
|
Theravance (TBPH) Q2 Loss Wider Than Expected, Revenues Rise Y/Y
|